Adoptive Cell Therapies: Keeping Pace With New and Emerging Advances

At JADPRO Live 2019, Patricia Mangan, RN, MSN, CRNP, and Edward Stadtmauer, MD, discussed the emerging world of chimeric antigen receptor (CAR) T-cell therapy, including the CAR T-cell process, approved indications and studies in hematologic malignancies, strategies for monitoring and managing emerg...

Descripción completa

Detalles Bibliográficos
Autores principales: Mangan, Patricia, Stadtmauer, Edward
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Harborside Press LLC 2020
Materias:
Meeting Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7857331/
https://www.ncbi.nlm.nih.gov/pubmed/33598318
http://dx.doi.org/10.6004/jadpro.2020.11.3.5
Descripción
Sumario:At JADPRO Live 2019, Patricia Mangan, RN, MSN, CRNP, and Edward Stadtmauer, MD, discussed the emerging world of chimeric antigen receptor (CAR) T-cell therapy, including the CAR T-cell process, approved indications and studies in hematologic malignancies, strategies for monitoring and managing emerging toxicities, and future directions in the use of this novel therapy.

Ejemplares similares